1. Home
  2. ESSA vs EDIT Comparison

ESSA vs EDIT Comparison

Compare ESSA & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESSA
  • EDIT
  • Stock Information
  • Founded
  • ESSA 1916
  • EDIT 2013
  • Country
  • ESSA United States
  • EDIT United States
  • Employees
  • ESSA N/A
  • EDIT N/A
  • Industry
  • ESSA Banks
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ESSA Finance
  • EDIT Health Care
  • Exchange
  • ESSA Nasdaq
  • EDIT Nasdaq
  • Market Cap
  • ESSA 206.9M
  • EDIT 176.7M
  • IPO Year
  • ESSA N/A
  • EDIT 2016
  • Fundamental
  • Price
  • ESSA $19.50
  • EDIT $1.32
  • Analyst Decision
  • ESSA
  • EDIT Buy
  • Analyst Count
  • ESSA 0
  • EDIT 14
  • Target Price
  • ESSA N/A
  • EDIT $8.08
  • AVG Volume (30 Days)
  • ESSA 13.4K
  • EDIT 3.3M
  • Earning Date
  • ESSA 01-22-2025
  • EDIT 11-04-2024
  • Dividend Yield
  • ESSA 3.08%
  • EDIT N/A
  • EPS Growth
  • ESSA N/A
  • EDIT N/A
  • EPS
  • ESSA 1.78
  • EDIT N/A
  • Revenue
  • ESSA $67,843,000.00
  • EDIT $61,759,000.00
  • Revenue This Year
  • ESSA N/A
  • EDIT N/A
  • Revenue Next Year
  • ESSA N/A
  • EDIT N/A
  • P/E Ratio
  • ESSA $10.96
  • EDIT N/A
  • Revenue Growth
  • ESSA N/A
  • EDIT 150.95
  • 52 Week Low
  • ESSA $15.29
  • EDIT $1.28
  • 52 Week High
  • ESSA $21.50
  • EDIT $11.58
  • Technical
  • Relative Strength Index (RSI)
  • ESSA 43.34
  • EDIT 24.88
  • Support Level
  • ESSA $19.58
  • EDIT $1.28
  • Resistance Level
  • ESSA $20.30
  • EDIT $2.37
  • Average True Range (ATR)
  • ESSA 0.54
  • EDIT 0.18
  • MACD
  • ESSA -0.15
  • EDIT -0.04
  • Stochastic Oscillator
  • ESSA 23.53
  • EDIT 6.45

About ESSA ESSA Bancorp Inc.

ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: